Martin A. Smith - 01 Sep 2022 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Martin A. Smith
Issuer symbol
IDXX
Transactions as of
01 Sep 2022
Net transactions value
-$2,100
Form type
4
Filing time
06 Sep 2022, 17:00:14 UTC
Previous filing
16 Feb 2022
Next filing
10 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +19 +63% $0.000000 49 01 Sep 2022 Direct F1
transaction IDXX Common Stock Tax liability $2,100 -6 -12% $349.93 43 01 Sep 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Options Exercise -19 -1.5% 1,241 01 Sep 2022 Common Stock 19 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 20 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2022 and June 30, 2022.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning September 1, 2022.
F3 Not applicable.